Western blotting and ELISA also validated the upregulation of C5a and IL‐1β in FGF19‐conditioned LX‐2 cells (Figure 5C,D; Figure S6A, Supporting Information), but not in CRC cells (Figure S6B, Supporting Information). This evidence concerns the gene IL1B and colorectal carcinoma.